Ultragenyx Pharmaceutical shares owned by Credit Suisse
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10M | 218k | 47.82 |
| 2023-09-30 | $8.9M | 249k | 35.65 |
| 2023-06-30 | $9.6M | 209k | 46.13 |
| 2023-03-31 | $7.1M | 177k | 40.10 |
| 2022-12-31 | $7.4M | 159k | 46.33 |
| 2022-09-30 | $5.8M | 141k | 41.41 |
| 2022-06-30 | $8.4M | 142k | 59.68 |
| 2022-03-31 | $8.9M | 122k | 72.59 |
| 2021-12-31 | $8.4M | 100k | 84.08 |
| 2021-09-30 | $6.5M | 72k | 90.22 |
| 2021-06-30 | $8.8M | 93k | 95.37 |
| 2021-03-31 | $7.7M | 68k | 113.40 |
| 2020-12-31 | $13M | 94k | 138.45 |
| 2020-09-30 | $5.5M | 72k | 76.92 |
| 2020-06-30 | $7.3M | 94k | 78.23 |
| 2020-03-31 | $7.1M | 160k | 44.42 |
| 2019-12-31 | $5.7M | 133k | 42.72 |
| 2019-09-30 | $3.2M | 90k | 35.71 |
| 2019-06-30 | $2.8M | 45k | 63.34 |
| 2019-03-31 | $2.9M | 41k | 69.37 |
| 2018-12-31 | $1.7M | 39k | 43.44 |
| 2018-09-30 | $3.0M | 39k | 76.35 |
| 2018-06-30 | $4.1M | 53k | 76.85 |
| 2018-03-31 | $2.9M | 58k | 50.99 |
| 2017-12-31 | $2.3M | 50k | 46.37 |
| 2017-09-30 | $6.8M | 128k | 53.24 |
| 2017-06-30 | $7.9M | 126k | 62.15 |
| 2017-03-31 | $9.8M | 144k | 67.77 |
| 2016-12-31 | $8.3M | 118k | 70.28 |
| 2016-09-30 | $8.5M | 119k | 70.94 |
| 2016-06-30 | $6.9M | 141k | 48.89 |
| 2016-03-31 | $5.4M | 85k | 63.31 |
| 2015-12-31 | $6.3M | 56k | 112.15 |
| 2015-09-30 | $5.2M | 54k | 96.28 |
| 2015-06-30 | $5.3M | 52k | 102.37 |
| 2015-03-31 | $2.1M | 34k | 62.15 |
| 2014-12-31 | $889k | 20k | 43.86 |
| 2014-09-30 | $710k | 11k | 62.50 |